
Research reference · Hormones
Ipamorelin
Ipamorelin is a synthetic pentapeptide growth-hormone secretagogue, first described in 1998 as selective for growth hormone release.
Published by Elevated Pharma ·
HormonesHuman research literature
Identity
What is Ipamorelin?
A synthetic pentapeptide ghrelin-receptor agonist (NNC 26-0161).
Research context
What has Ipamorelin been studied for?
Human data are limited to pharmacokinetic modeling in volunteers and one phase 2 trial in postoperative ileus.
Evidence boundary
What does the research not show?
A small clinical literature does not establish broad safety or effectiveness.
U.S. status · November 7, 2026
Is Ipamorelin FDA-approved?
Not FDA-approved. Ipamorelin was not on FDA’s 2026 compounding advisory agendas.
Key studies
The main Ipamorelin research
Selected from PubMed: human trials first, then reviews, then foundational laboratory work. Each finding applies to the material and setting studied.
- Ipamorelin, the first selective growth hormone secretagogue.
- Study type
- Animal study
- Journal · year · PMID
- Eur J Endocrinol · 1998 · 9849822
- What it covers
- Original characterization.
- Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.
- Study type
- Human clinical study
- Journal · year · PMID
- Pharm Res · 1999 · 10496658
- What it covers
- Human pharmacology.
- Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.
- Study type
- Human RCT · phase 2
- Journal · year · PMID
- Int J Colorectal Dis · 2014 · 25331030
- What it covers
- Postoperative bowel recovery trial.
- Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives.
- Study type
- Review
- Journal · year · PMID
- Int J Mol Sci · 2026 · 42123471
- What it covers
- Recent overview including GH secretagogues.
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
- Study type
- Review
- Journal · year · PMID
- Sports Med · 2026 · 41966639
- What it covers
- Compares approved and unapproved peptides discussed in sports medicine, with attention to safety data.
Search all 51 PubMed records for Ipamorelin · Counts and selections checked November 7, 2026.
Reference identifiers
Ipamorelin identity data
Database identity describes the reference substance, not any specific material or lot.
- Primary name
- Ipamorelin
- Also indexed as
- NNC 26-0161
- Molecular formula
- C38H49N9O5
- Molecular mass
- 711.9 g/mol
- PubChem CID
- 9831659
Official & primary sources
Regulatory and database records
Citation does not imply an Elevated Pharma partnership or endorsement.